Inventor

SHIZUKA MANAMI

US30 patents

⚠️ This page may combine multiple inventors who share the name “SHIZUKA MANAMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHIZUKA MANAMI

IMMUNOGEN INC

Cytotoxic benzodiazepine derivatives

Cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Cytotoxic benzodiazepine derivatives

Cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Methods for preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-6-ones

Methods of preparing cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

Process for preparing substituted indolines

Methods of preparing cytotoxic benzodiazepine derivatives

Cytotoxic benzodiazepine derivatives

Methods of preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indoles

Methods of preparing cytotoxic benzodiazepine derivatives

Conjugates comprising cell-binding agents and cytotoxic agents

Conjugates comprising cell-binding agents and cytotoxic agents

Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders

Cytotoxic benzodiazepine derivatives

Methods of preparing cytotoxic benzodiazepine derivatives

MERCK SHARP & DOHME

2,6,7 substituted purines as HDM2 inhibitors

2,6,7,8 substituted purines as HDM2 inhibitors

Substituted imidazopyridines as HDM2 inhibitors

Substituted imidazopyridines as HDM2 inhibitors

Substituted piperidines as HDM2 inhibitors

BOGEN STEPHANE L

Substituted piperidines that increase p53 activity and the uses thereof